The selectable marker human dihydrofolate reductase enables sequential genetic manipulation of the Plasmodium berghei genome
- 5 March 2000
- journal article
- Published by Elsevier BV in Molecular and Biochemical Parasitology
- Vol. 106 (2), 199-212
- https://doi.org/10.1016/s0166-6851(99)00189-9
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Precise Timing of Expression of a Plasmodium falciparum- derived Transgene in Plasmodium berghei Is a Critical Determinant of Subsequent Subcellular LocalizationPublished by Elsevier BV ,1998
- Stable transgene expression in Plasmodium falciparumMolecular and Biochemical Parasitology, 1997
- TRAP Is Necessary for Gliding Motility and Infectivity of Plasmodium SporozoitesCell, 1997
- Targeted Gene Disruption Shows That Knobs Enable Malaria-Infected Red Cells to Cytoadhere under Physiological Shear StressCell, 1997
- Circumsporozoite protein is required for development of malaria sporozoites in mosquitoesNature, 1997
- Stable Transfection of Malaria Parasite Blood StagesScience, 1995
- Stable molecular transformation of Toxoplasma gondii: a selectable dihydrofolate reductase-thymidylate synthase marker based on drug-resistance mutations in malaria.Proceedings of the National Academy of Sciences, 1993
- Analogues of N-benzyloxydihydrotriazines:in vitroantimalarial activity againstPlasmodium falciparumPathogens and Global Health, 1986
- Babesia rodhainiandPlasmodium bergheiPathogens and Global Health, 1981
- The antimalarial activity of N-benzyloxydihydrotriazinesPathogens and Global Health, 1980